analiza aiqbench

This partnership highlights a critical business model shift in AI-driven biotech, where companies are trading access to proprietary datasets for foundational models rather than relying solely on discretionary fees. The deal underscores the growing economic value of RNA foundation models like TxFM and the strategic importance of securing long-term data licenses for training advanced machine learning systems.